Impact of perioperative dexmedetomidine on recurrence and survival outcomes in oral cavity squamous cell carcinoma
Perioperative DEX use is independently associated with increased risks of LRR and DM in OCSCC patients. These results underscore the importance of cautious perioperative management and the need for prospective validation in randomised clinical trials.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Jiaqiang Zhang (ORCID: https://orcid.org/0000-0002-1367-9644)
- Peilin Xie
- Mingyang Sun (ORCID: https://orcid.org/0000-0003-1136-3766)
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Henan Provincial People's Hospital (CN)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- BMJ Health & Care Informatics
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1136/bmjhci-2024-101344
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China